ARTICLE | Company News
STC Biologics, Immune Pharmaceuticals deal
June 29, 2015 7:00 AM UTC
Immune and STC partnered to accelerate the development NanomAbs antibody-drug conjugates for targeted chemotherapeutics delivery. The partners will focus on HER2-targeted paclitaxel nanoparticles usin...